Dr. Christopher O. Ike, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,324
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of Texas Medical Branch at Galveston
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
GA license 70218 -
Cardiovascular Disease Physician
NC license 2005-00555 -
Internal Medicine Physician
NC license 2005-00555
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Flowers Hospital Dothan, AL
- Medical Center Enterprise Enterprise, AL
- Dale Medical Center Ozark, AL
- Mizell Memorial Hospital Opp, AL
- Medical Center Barbour Eufaula, AL
Medical groups
- Cardiology Associates, PA (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,324
- Services billed
- 3,249
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 574 | 463 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | 171 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 110 | 51 |
| Established patient office or other outpatient visit, 20-29 minutes | 109 | 94 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 97 | 36 |
| Established patient office or other outpatient visit, 30-39 minutes | 87 | 78 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 56 | 56 |
| Injection, regadenoson, 0.1 mg | 52 | 13 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 49 | 49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 44 | 44 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Dothan, AL | 86 |
| Eliquis (apixaban) Other prescribers in Dothan, AL | 80 |
| Metoprolol Tartrate Other prescribers in Dothan, AL | 68 |
| Atorvastatin Calcium Other prescribers in Dothan, AL | 51 |
| Carvedilol Other prescribers in Dothan, AL | 51 |
| Entresto (sacubitril/valsartan) Other prescribers in Dothan, AL | 37 |
| Amlodipine Besylate Other prescribers in Dothan, AL | 35 |
| Hydrochlorothiazide Other prescribers in Dothan, AL | 34 |
| Lisinopril Other prescribers in Dothan, AL | 34 |
| Ranolazine Er (ranolazine) Other prescribers in Dothan, AL | 33 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 44 payments worth $1,534 in total to this clinician.
| Boston Scientific Corporation | $762 |
|---|---|
| Pfizer Inc. | $232 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $203 |
| E.r. Squibb & Sons, L.l.c. | $119 |
| Novartis Pharmaceuticals Corporation | $116 |
| Philips North America LLC | $52.20 |
| AstraZeneca Pharmaceuticals LP | $19.01 |
| Asahi Intecc USA, Inc. | $16.30 |
| Food and Beverage | $960 |
|---|---|
| Travel and Lodging | $574 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Sep 19, 2025 | Travel and Lodging General - Vascular Access · General - Vascular Access_IC · travel to Atlanta, GA · in-kind | $382 |
| Boston Scientific Corporation Sep 19, 2025 | Travel and Lodging General - Vascular Access · General - Vascular Access_IC · travel to Atlanta, GA · in-kind | $192 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.